Working… Menu
Trial record 47 of 297 for:    colon cancer AND Capecitabine AND chemotherapy

Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer. (EXECC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03577392
Recruitment Status : Recruiting
First Posted : July 4, 2018
Last Update Posted : April 4, 2019
Jiangsu Simcere Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
ming zeng, MD, Sichuan Provincial People's Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 1, 2019
Estimated Study Completion Date : August 1, 2021